ArticleBone marrow transplantation2025
Feasibility and efficacy of partial replacement of post transplantation cyclophosphamide with bendamustine on day +4 for graft versus host disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation.
Velu Nair et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it